CH454880A - Verfahren zur Herstellung von Thiaminkomplexen - Google Patents

Verfahren zur Herstellung von Thiaminkomplexen

Info

Publication number
CH454880A
CH454880A CH1672764A CH1672764A CH454880A CH 454880 A CH454880 A CH 454880A CH 1672764 A CH1672764 A CH 1672764A CH 1672764 A CH1672764 A CH 1672764A CH 454880 A CH454880 A CH 454880A
Authority
CH
Switzerland
Prior art keywords
thiamine
complexes
preparation
thiamine complexes
Prior art date
Application number
CH1672764A
Other languages
English (en)
Inventor
Yamamoto Ryuichi
Shima Kazuhiro
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of CH454880A publication Critical patent/CH454880A/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51Thiamines, e.g. vitamin B1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
CH1672764A 1963-12-28 1964-12-28 Verfahren zur Herstellung von Thiaminkomplexen CH454880A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7122263 1963-12-28

Publications (1)

Publication Number Publication Date
CH454880A true CH454880A (de) 1968-04-30

Family

ID=13454414

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1672764A CH454880A (de) 1963-12-28 1964-12-28 Verfahren zur Herstellung von Thiaminkomplexen

Country Status (4)

Country Link
US (1) US3398226A (de)
CH (1) CH454880A (de)
FR (2) FR1604904A (de)
GB (1) GB1043007A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR88903E (fr) * 1964-06-19 1967-04-14 Oreal Nouveaux polymères polysulfhydrylés et leurs applications
US5488075A (en) * 1994-09-20 1996-01-30 Guha; Sujoy K. Contraceptive for use by a male

Also Published As

Publication number Publication date
GB1043007A (en) 1966-09-21
DE1520906B2 (de) 1972-09-21
FR1604904A (en) 1971-05-15
FR4733M (de) 1967-01-09
US3398226A (en) 1968-08-20
DE1520906A1 (de) 1970-02-19

Similar Documents

Publication Publication Date Title
CH463787A (de) Verfahren zur Herstellung von Polyiminolactonen
CH479595A (de) Verfahren zur Herstellung von 1-Peracylglycosyl-5-azacytosinen
CH444868A (de) Verfahren zur Herstellung von Fluoracylaziridinen
CH471134A (de) Verfahren zur Herstellung von Pyrazinoylbenzamidinen
CH466300A (de) Verfahren zur Herstellung von Dihydrotriazinen
CH469696A (de) Verfahren zur Herstellung von 2-Guanidino-alkylchromanen
CH449623A (de) Verfahren zur Herstellung von 4-Alkyl-5-cyan-oxazolen
CH438286A (de) Verfahren zur Herstellung von Dibenzocycloheptadien-ketoxim-O-äthern
AT244338B (de) Verfahren zur Herstellung von 3-Amino-isoxazolen
CH466272A (de) Verfahren zur Herstellung von Cycloalkylmethylaminobenzophenonen
CH440240A (de) Verfahren zur Herstellung von Fluorjodalkanen
CH426836A (de) Verfahren zur Herstellung von Naphthindolizinchinonen
CH456579A (de) Verfahren zur Herstellung von Diphenylbenzocycloalkenen
CH430716A (de) Verfahren zur Herstellung von trans-2-Phenyl-3-methylmorpholin
CH454880A (de) Verfahren zur Herstellung von Thiaminkomplexen
CH470376A (de) Verfahren zur Herstellung von 17a-Äthinyl-19-nor-testosteron
CH459973A (de) Verfahren zur Herstellung von Acetylacetamiden
CH450378A (de) Verfahren zur Herstellung von B-Hydroxyäthylthiocelestosaminid
CH416106A (de) Verfahren zur Herstellung von Polydodecalactam
CH479570A (de) Verfahren zur Herstellung von 7a-Alkyl-19-nor-steroiden
CH425809A (de) Verfahren zur Herstellung von Pyridazoniminen
CH432536A (de) Verfahren zur Herstellung von Diamino-monoazidotriazinen
CH447211A (de) Verfahren zur Herstellung von Diaminodihydroxy-anthrachinonen
CH424793A (de) Verfahren zur Herstellung von 4-Nitro-5-hydroxy-pyridazonen-6
CH442340A (de) Verfahren zur Herstellung von Aminoalkyl-1-naphthylacetamiden